These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7879042)

  • 1. Preclinical study of a recombinant soluble tumor necrosis factor receptor: effect on immune response of renal allograft recipients.
    Wee S; Boskovic S; Eason JD; Widmer MB; Benedict Cosimi A
    Transplant Proc; 1995 Feb; 27(1):411-2. PubMed ID: 7879042
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human dimeric tumor necrosis factor receptor (TNFR:Fc) as an immunosuppressive agent in renal allograft recipients.
    Eason JD; Wee SL; Kawai T; Hong HZ; Powelson J; Widmer M; Cosimi AB
    Transplant Proc; 1995 Feb; 27(1):554. PubMed ID: 7879095
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the effects of TNF in renal allograft recipients using recombinant human dimeric tumor necrosis factor receptors.
    Eason JD; Wee S; Kawai T; Hong HZ; Powelson JA; Widmer MB; Cosimi AB
    Transplantation; 1995 Jan; 59(2):300-5. PubMed ID: 7839455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies.
    Delmonico FL; Knowles RW; Colvin RB; Cavender DE; Kawai T; Bedle M; Stroka D; Preffer FI; Haug C; Cosimi AB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):784-5. PubMed ID: 8438479
    [No Abstract]   [Full Text] [Related]  

  • 5. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.
    Kawaguchi T; Hoshino Y; Rahman F; Amano Y; Higashi H; Kataoka H; Ohtsuki M; Teshima K; Chiba K; Kakefuda T; Suzuki S
    Transplant Proc; 1996 Apr; 28(2):1062-3. PubMed ID: 8623227
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
    van Gelder T; Zietse R; Yzermans JN; Rischen-Vos J; Vaessen LM; Weimar W
    Transplant Proc; 1996 Dec; 28(6):3221-2. PubMed ID: 8962247
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression in kidney transplantation in Poland.
    Paczek L; Lao M; Durlik M; Szmidt J; Rowinski W
    Transplant Proc; 2004 Mar; 36(2 Suppl):173S-176S. PubMed ID: 15041331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
    Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
    Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog.
    Ferraresso M; Knight R; Tu Y; Stepkowski SM; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3028. PubMed ID: 7940953
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.
    Vanrenterghem Y; Peeters J
    Transplant Proc; 1996 Aug; 28(4):2097-9. PubMed ID: 8769165
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
    Robertson A; Plenter R; Francis DM; Clunie GJ
    Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
    Maeda H; Sakamoto K; Kashiwabara H; Hachisu T; Yamada H; Matsushita K; Yamada K; Yokoyama T
    Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
    Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
    Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of cyclosporine in renal transplantation: experience at the University of Padua.
    Furian L; Baldan N; Rigotti P
    Transplant Proc; 2004 Mar; 36(2 Suppl):148S-151S. PubMed ID: 15041326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent early immune response after kidney transplantation in patients of the European senior transplant program.
    Pratschke J; Merk V; Reutzel-Selke A; Pascher A; Denecke C; Lun A; Said A; Schönemann C; Ulrich F; Reinke P; Frei U; Neuhaus P; Tullius SG
    Transplantation; 2009 Apr; 87(7):992-1000. PubMed ID: 19352117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplantation in cyclosporine immunosuppressed infants and children.
    Benedetti E; Hakim NS; Matas AJ; Payne WD; Mauer SM; Nevins T; Kashten C; Chavers B; Najarian JS
    Transplant Proc; 1994 Oct; 26(5):2766-7. PubMed ID: 7940871
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts.
    Asano T; Murai M; Nakamura H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):761-2. PubMed ID: 8438471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.